Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report

BACKGROUND: Direct-acting antivirals (DAAs) dramatically improve the treatment of hepatitis C virus (HCV) infections. However, the effects of DAAs on extra-hepatic manifestations such as HCV-associated glomerulonephritis, especially in cases with renal dysfunction, are not well elucidated. CASE PRES...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Nephrol
Main Authors: Shimada, Michiko, Nakamura, Norio, Endo, Tetsu, Yamabe, Hideaki, Nakamura, Masayuki, Murakami, Reiichi, Narita, Ikuyo, Tomita, Hirofumi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5372252/
https://ncbi.nlm.nih.gov/pubmed/28356063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0534-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados